《生命科学》 2025, 37(10): 1312-1321
胰岛类器官治疗1型糖尿病:前沿探索与临床应用
摘 要:
胰岛类器官(pancreatic islet organoids, PIOs) 可以在体外由干细胞诱导分化获得,其在受到高浓度葡萄糖刺激时能够分泌胰岛素,因此被认为是治疗1 型糖尿病(type 1 diabetes mellitus, T1DM) 的可行方案。本文通过系统梳理PIOs 治疗T1DM 的前沿探索和临床应用,旨在为后续研究提供全面参考,推动该领域不断发展,加速PIOs 治疗T1DM 的临床应用转化,以期为患者带来更有效的治疗选择,改善其生活质量和预后。
通讯作者:蔡晶晶 , Email:caijingjing@ahyz.edu.cn
Abstract:
Pancreatic islet organoids (PIOs), which can be derived in vitro through the induced differentiation of stem cells, are capable of secreting insulin in response to high-glucose stimulation. Consequently, they are regarded as a promising therapeutic strategy for type 1 diabetes mellitus (T1DM). This article systematically reviews the current research advancements and clinical applications of PIOs in treating T1DM, aiming to provide a comprehensive reference for future studies, promote ongoing progress in this field, accelerate the clinical translation of PIO-based therapies for T1DM, and ultimately offer patients more effective treatment options to improve their quality of life and prognosis.
Communication Author:CAI Jing-Jing , Email:caijingjing@ahyz.edu.cn